Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCT01 in Critical Limb Ischemia
NCT01867190Phase 2Completed
- Sponsor
- Lifecells, LLC
- Start
- May 2013
- Primary completion
- Mar 2016
- Modality
- Bone Marrow HSCs, Bone Marrow MSCs, Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of ASCT 01 in critical limb ischemia (CLI), sponsored by Lifecells, LLC. Started May 2013; status: completed.
02
Drugs
ASCT 01
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01867190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01867190.